Back to all articles

Sarcopenia: Muscle Loss, Diagnosis and Treatment 2026

Updated
Reviewed by the Healthi Life Medical Team
Sarcopenia: Muscle Loss, Diagnosis and Treatment 2026

Sarcopenia causes progressive muscle loss after 40. Learn how it is diagnosed, what biomarkers matter, and which interventions work.

This page is for general information and does not constitute medical advice, diagnosis, or treatment. Results vary between individuals. Every medicine and peptide listed here is dispensed only after a medical consultation at Healthi Life and on a physician's prescription. Prices are published for transparency, not as an offer to supply. Always consult a qualified physician about your condition. See our full medical disclaimer.

Sarcopenia is the progressive loss of skeletal muscle mass, strength, and function that begins in the fourth decade and accelerates after 60. It is not normal aging. It is a diagnosable condition with measurable thresholds, specific biomarkers, and evidence-based interventions. The name comes from Greek: sarx for flesh, penia for loss. Prevalence varies by definition and population; a 2017 meta-analysis of general population studies estimated it at about 10% of men and 10% of women aged 60 and over. The consequences include falls, fractures, metabolic dysfunction, loss of independence, and increased mortality.

What Sarcopenia Is and How It Progresses

Sarcopenia is defined by three components: low muscle mass, low muscle strength, and low physical performance. All three are measured. Muscle mass is assessed by imaging or bioelectrical impedance. Strength is tested with handgrip dynamometry or chair stand tests. Performance is evaluated through gait speed or the Short Physical Performance Battery. This guide is published by the Healthi Life longevity clinic in Bangkok.

The revised European consensus (EWGSOP2, Age and Ageing) sets the threshold for low strength at handgrip strength below 27 kg for men and below 16 kg for women. Gait speed of 0.8 meters per second or less indicates low physical performance, which classifies sarcopenia as severe. Appendicular skeletal muscle mass, adjusted for height, falls below 7.0 kg/m² in men and 5.5 kg/m² in women.

Sarcopenia diagnostic criteria

Muscle loss begins around age 40. The rate is gradual at first, then accelerates after 60. The decline is not linear. It accelerates with inactivity, illness, poor nutrition, and hormonal changes.

Mechanisms Behind Muscle Loss

Sarcopenia results from an imbalance between muscle protein synthesis and muscle protein breakdown. Synthesis declines with age. Breakdown increases. The net effect is atrophy.

Anabolic resistance develops over time. Older muscle responds less to dietary protein and resistance exercise. Insulin resistance, mitochondrial dysfunction, inflammation, and reduced satellite cell activity all contribute.

Hormonal changes accelerate the process. Testosterone, growth hormone, and insulin-like growth factor-1 decline. Cortisol and inflammatory cytokines rise. The result is a chronic catabolic state.

Neurological factors also matter. Motor units are lost with age. The remaining units enlarge but cannot fully compensate. Muscle fiber denervation leads to atrophy and fibrosis. This is why strength declines faster than mass.

How Sarcopenia Is Diagnosed

Diagnosis requires measurement, not assumption. The International Clinical Practice Guidelines for Sarcopenia (ICFSR, 2018) recommend annual screening of adults aged 65 and over with a rapid tool such as gait speed or the SARC-F questionnaire, followed by confirmation with objective tests.

Screening tools include the SARC-F questionnaire, which asks five questions about strength, assistance with walking, rising from a chair, climbing stairs, and falls. A score of 4 or higher warrants further testing.

Confirmation begins with handgrip strength. EWGSOP2 makes low strength the primary parameter, because strength predicts adverse outcomes better than mass. A Jamar dynamometer is the standard. Three trials per hand, best score recorded. Below the threshold, proceed to muscle mass assessment.

Testing Methods and Accuracy

Dual-energy X-ray absorptiometry (DEXA) is the most widely available imaging method for muscle mass, while EWGSOP2 considers MRI and CT the gold standards. It separates lean tissue from fat and bone with high precision. Appendicular lean mass is the sum of muscle in the arms and legs. This value is divided by height squared to generate the skeletal muscle index.

Bioelectrical impedance analysis (BIA) is faster and less expensive. It estimates muscle mass by measuring electrical conductivity through the body. Accuracy depends on hydration status and device quality. Clinical-grade devices with segmental analysis are reliable when calibrated against DEXA.

CT and MRI provide the most detailed images. They quantify muscle area, density, and fat infiltration. A single slice at the third lumbar vertebra correlates strongly with total body muscle mass. These methods are used in research and when other tests are inconclusive.

Test Measures Precision Accessibility
Handgrip dynamometry Strength High High
DEXA Muscle mass High (widely available) Moderate
BIA Muscle mass Moderate High
CT/MRI Muscle area and quality Very high Low

Blood biomarkers are not diagnostic but provide context. Vitamin D, testosterone, IGF-1, albumin, and inflammatory markers such as C-reactive protein and interleukin-6 help identify contributing factors. A comprehensive diagnostic check-up that includes these blood panels gives a physician the data needed to confirm sarcopenia and design a protocol.

Nutrition Interventions That Work

Protein intake is the first intervention. The PROT-AGE study group recommends at least 1.0 to 1.2 grams per kilogram of body weight per day for older adults, higher than the standard 0.8 g/kg. During illness or recovery, the target rises to 1.2 to 1.5 g/kg.

Protein distribution strategy

Leucine is the key amino acid. It activates the mTOR pathway, which drives muscle protein synthesis. Each meal should provide a meaningful serving of high-quality protein. Sources include whey, eggs, chicken, fish, and soy.

Distribution matters. Spreading protein evenly across three or four meals is more effective than concentrating it in one. A 2014 crossover study in the Journal of Nutrition found that 24-hour muscle protein synthesis was 25% higher with evenly distributed protein than with skewed intake, in healthy adults with a mean age of about 37.

Supplements and Evidence

Whey protein is the most studied. It is rapidly absorbed, high in leucine, and consistently shown to increase muscle mass and strength when combined with resistance training.

Creatine monohydrate improves strength and muscle mass. It increases phosphocreatine stores in muscle, which enhances ATP production during high-intensity contractions. Benefits in older adults appear mainly when it is combined with resistance exercise.

Vitamin D is essential. Deficiency is common in older adults and correlates with low muscle mass and strength. Supplementation, when needed, is set by a physician based on blood testing.

Omega-3 fatty acids may reduce anabolic resistance. Studies are mixed, but a 2015 six-month trial in the American Journal of Clinical Nutrition found that fish oil-derived omega-3 therapy increased thigh muscle volume and strength in healthy adults aged 60 to 85.

Exercise Protocols and Resistance Training

Resistance training is the first-line therapy recommended by the ICFSR guidelines to improve muscle strength, mass, and physical function in older adults. The Nature Reviews Disease Primers overview of sarcopenia identifies it as the cornerstone of treatment.

The prescription is specific. Two to three sessions per week. Six to eight exercises covering all major muscle groups. Two to three sets per exercise. Repetitions and load are set by a qualified professional and adjusted to the individual.

Progressive overload is required. Load, volume, or intensity must increase over time. Without progression, adaptation stops.

Combining Exercise and Protein

The post-exercise window matters. Muscle protein synthesis is elevated for 24 to 48 hours after resistance training. Protein consumed within two hours of exercise is used more efficiently than protein consumed at other times. The right amount depends on body weight and training volume.

Power training may be more effective than traditional strength training. Power is the product of force and velocity. It declines faster with age than strength. Exercises performed at high speed with moderate load improve both power and functional performance.

Balance and mobility work reduce fall risk. Tai chi, yoga, and targeted balance exercises improve proprioception and reaction time. The evidence is strong. A Cochrane review of exercise in adults aged 60 and over found that exercise reduced the rate of falls by 23%.

Medical and Emerging Treatments

Testosterone replacement increases muscle mass and strength in hypogonadal men. Deficiency is confirmed by a physician with repeated early-morning blood tests and symptoms before any treatment is considered.

Women do not benefit from testosterone in the same way. Estrogen replacement during and after menopause may slow muscle loss, though the data are less clear.

Selective androgen receptor modulators (SARMs) are in development. They aim to provide the anabolic effects of testosterone without the androgenic side effects. Enobosarm is the most studied. A phase II trial in older men and postmenopausal women showed increases in lean mass and physical function, but no SARM is approved for sarcopenia.

Peptides and Growth Factors

Growth hormone secretagogues are being tested. These include peptides such as ipamorelin and tesamorelin, which stimulate endogenous growth hormone release.

Myostatin inhibitors are another target. Myostatin is a protein that limits muscle growth. Blocking it increases muscle mass in animal models. Bimagrumab, a monoclonal antibody against the activin type II receptor, increased lean mass in a 2020 randomized trial in adults aged 70 and over with sarcopenia, but did not improve physical function more than exercise and nutrition alone.

The Nature Reviews Drug Discovery article on innovative treatments outlines the current pipeline. Most candidates are years from approval. The emphasis remains on proven interventions: protein, resistance training, and targeted hormone replacement when deficiency is documented.

Peptide therapy is available at physician-led clinics, where protocols are tailored to biomarker results and supervised throughout. The consultation, testing, and prescription process ensures that any intervention is medically appropriate.

Measuring Progress and Adjusting Protocols

Progress is tracked with the same tests used for diagnosis. Handgrip strength is repeated every four to six weeks. DEXA or BIA every three to six months. Gait speed and chair stand tests monthly.

The expected rate of improvement is modest. Strength usually improves before muscle mass, and the pace varies from person to person.

Biomarkers guide adjustment. If vitamin D remains low despite supplementation, the dose is increased or absorption is investigated. If testosterone is below target, the replacement protocol is reviewed. If inflammation markers rise, the physician looks for infection, injury, or overtraining.

  • Repeat handgrip strength every four to six weeks
  • Reassess muscle mass every three to six months with DEXA or BIA
  • Track gait speed and functional tests monthly
  • Review blood biomarkers quarterly

Not all individuals respond equally. Genetic variation, medication use, comorbidities, and adherence all affect outcomes. Some older adults show minimal response to resistance training despite good adherence. These cases require deeper investigation and individualized protocols.

Intervention Expected Change Timeframe
Resistance training Strength gain (varies by individual) 12 weeks
Protein supplementation Lean mass support (varies by individual) 12 weeks
Testosterone replacement (men) Lean mass gain when deficiency is confirmed (varies) 6 months
Combined exercise + protein Lean mass and strength gain (varies by individual) 12 weeks

Sarcopenia in the Context of Longevity

Muscle is an endocrine organ. It secretes myokines that regulate metabolism, inflammation, and cognitive function. Low muscle mass correlates with insulin resistance, cardiovascular disease, osteoporosis, and dementia.

Maintaining muscle is not about aesthetics. It is about metabolic health, independence, and lifespan. In the PURE study (The Lancet, 2015), grip strength was a stronger predictor of all-cause and cardiovascular mortality than systolic blood pressure. These are not coincidences. They reflect the central role of muscle in energy balance, immune function, and resilience.

Integration with Other Health Metrics

Sarcopenia does not occur in isolation. It often coexists with osteoporosis, frailty, and metabolic syndrome. A comprehensive longevity program addresses all three. Bone density, muscle mass, and metabolic health are interconnected. Weight-bearing exercise improves bone and muscle. Protein supports both. Vitamin D, calcium, and magnesium are essential for both systems.

Hormone optimization is part of the picture. Low testosterone in men and low estrogen in women accelerate both muscle and bone loss. Replacement therapy, when indicated, addresses both. The decision is made after testing and discussion with a physician. Not everyone is a candidate. The risks and benefits vary by individual.

Inflammation is another common thread. Chronic low-grade inflammation, measured by C-reactive protein and interleukin-6, drives muscle breakdown and impairs recovery. Anti-inflammatory interventions, including omega-3 supplementation, polyphenol-rich foods, and stress management, are part of the protocol.

Frequently Asked Questions

Can sarcopenia be reversed?

Yes, if diagnosed early. Resistance training and adequate protein intake increase muscle mass and strength at any age. Reversal is harder in advanced cases, but improvement is possible.

How much protein is enough?

The target is 1.0 to 1.2 grams per kilogram of body weight per day for maintenance, and 1.2 to 1.5 g/kg during illness or active treatment. For a 70 kg individual, that is 70 to 105 grams per day. Distribution across three to four meals is more effective than consuming it all at once.

Is muscle loss normal with age?

Muscle loss is common but not inevitable. The rate is influenced by activity, nutrition, hormones, and genetics. Sedentary individuals lose muscle faster. Those who maintain resistance training and protein intake preserve muscle into their 80s. Hormone levels by age also affect the rate of decline, particularly testosterone in men.

When should I test for sarcopenia?

ICFSR guidelines recommend annual screening from age 65, or earlier if there are risk factors such as weight loss, falls, or chronic illness. Handgrip strength and gait speed can be tested in a single visit. If either is below threshold, proceed to imaging and blood work. Screening is repeated annually or when symptoms change.


Sarcopenia is measurable, treatable, and, in many cases, reversible. The interventions are straightforward: resistance training, adequate protein, hormone optimization when deficient, and regular monitoring. Healthi Life builds these into longevity programs that track strength, physical function, and metabolic markers, then track them over months under physician supervision. Visit Healthi Life to begin with a diagnostic assessment and a protocol tailored to your data.

This page is for information only and is not medical advice. Medical consultation and prescription are available online and on site at Healthi Life, Ekkamai, Bangkok.

Every medicine named on this page is dispensed only after a medical consultation at Healthi Life and on a physician's prescription. No dosing schedule is published here; the dose is set by the prescribing physician. This page is published for transparency, not as an offer to supply.

  • 5.0 Google Rating · 238 reviews
  • 2,500+ Guests
  • 50+ Countries
  • 2025 Regenerative Clinic of the Year in Asia-Pacific — GlobalHealth Asia-Pacific Awards
Reviewed by the Healthi Life Medical Team